Publikationsserver der Universitätsbibliothek Marburg
Titel:Initial 24-Hour ICU Glucose Levels are Associated with the Development of Cerebral Vasospasm after Subarachnoid Haemorrhage
Autor:Breiding, Philipe Sebastian
Weitere Beteiligte: Geldner, Götz (Prof. Dr. med.)
Veröffentlicht:2017
URI:https://archiv.ub.uni-marburg.de/diss/z2017/0796
DOI: https://doi.org/10.17192/z2017.0796
URN: urn:nbn:de:hebis:04-z2017-07963
DDC: Medizin
Titel (trans.):Initiale 24-Stunden Intensivstation Glukosewerte sind mit der Entstehung eines zerebralen Vasospasmus nach Subarachnoidalblutung verbunden
Publikationsdatum:2017-12-21
Lizenz:https://creativecommons.org/licenses/by-nc-sa/4.0

Dokument

Schlagwörter:
CVS, CVS, Subarachnoid Haemorrhage, SAB, Glukose, Vasospasmus, zerebraler Vasospasmus, SAB, Cerebral Vasospasm, CVS, Vasospasm, SAH, Glucose, Subarachnoidalblutung, Subarachnoidalblutung, Vasospasmus, zerebraler Vasospasmus, Glukose

Summary:
Cerebral vasospasm (CVS) is a well-known cause of morbidity and mortality amongst patients who have suffered from subarachnoid haemorrhage (SAH). Its presence is associated with reduced cerebral perfusion and potential further development of neurological deficit. The aetiology of CVS has been proven to be multifactorial and several risk factors have been associated with its development. Since CVS has been linked to signalling changes in vascular endothelium, serum glucose was chosen as a potential prognostic indicator and risk factor due to its relation with endothelial dysfunction. The objective of this study was to evaluate the association between serum glucose levels in ICU patients admitted with SAH and the development of CVS. The study is a retrospective observational study in which data was collected on patients admitted to the ICU of Pauls Stradiņš Clinical University Hospital with the primary diagnosis of SAH. We compared serum glucose levels on ICU admission and average glucose levels for the first 5 days in the ICU in patients with and without subsequent development of CVS. Twenty-four patients diagnosed with SAH were included in the study. CVS was confirmed in 25% (n=6). There was no significant difference in age and gender distribution between groups. Patients with subsequent development of CVS had higher WFNS score values (4.80 and 3.56; p=0.008). We found lower mean glucose levels on admission for patients that developed CVS compared to those that did not develop CVS (7.32 and 9.28 mmol/L; p=0.05). The average glucose levels on first 24h of ICU stay were also lower in patients who developed CVS (7.26 and 9.29 mmol/L; p=0.03). There were no significant differences in average glucose levels between groups from day 2 to day 5 of ICU stay. Overall mortality was not affected by ICU glucose levels and average glucose levels of first 24h were negatively correlated to the duration of ICU stay (rs = -0.408, p<0.05). The study shows that admission and initial average 24h glucose levels may prove to be a prognostic indicator for the potential development of CVS after SAH. Glucose averages of the first day of ICU stay were significantly related to the development of CVS and may demonstrate importance after further investigation, possibly with a larger patient group.

Bibliographie / References

  1. Patienten, die ZVS entwickelten (7.32 und 9.28 mmol/L; p=0.05). Die Glukose-Mittelwerte in den ersten 24 Stunden des Aufenthalts zeigten sich auch niedriger bei Patienten, die ZVS
  2. Yoshino, T. et. al. A case of hypoglycemic hemiparesis and literature review. Ups J Med Sci. 2012. 117(3):347-51
  3. Cagiran, E. et. al. Admission Blood Glucose and Morbidity-Mortality in Subarachnoid Hemorrhage Patient. Journal of Neurological Sciences (Turkish). 2013. V.30N.1P.168-177
  4. Sato, M. et. al. Admission blood glucose levels and early change of neurological grade in poor-grade patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien).
  5. Suarez, J.I., Tarr, R.W., Selman, W.R. Aneurysmal subarachnoid haemorrhage. N Engl J Med, 2006. 354(4):387-96
  6. Diecke, O. Angiospastic hemiplegia as hypoglycemic reaction. Dtsch Med Wochenschr. 1928. 54:1375-80
  7. Zubkov, A.Y., Ogihara, K., Bernanke, D.H., Parent, A.D., Zhang, J. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol. 2000. 53:260-266
  8. Macdonald, R.L., Weir, B.K. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991. 22:971-982
  9. Ecker, A., Riemenschneider, P.A. Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg. 1951. 8:660-667
  10. Jung, C.S., et. al. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg. 2004. 101:836-842
  11. Gull, W.M. Cases of aneurism of the cerebral vessels. Guys Hosp Rep. 1859. 5:281-304
  12. Sercombe, R., Dinh, Y.R., Gomis, P. Cerebrovascular inflammation following subarachnoid haemorrhage. Jpn J Pharmacol. 2002. 88:227-249
  13. Hunt, W.E. Clinical assessment of SAH. J Neurosurg. 1983. 59:550-551
  14. Keyrouz, S.G., Diringer, M.N. Clinical review: Prevention and therapy of vasospasm in subarachnoid haemorrhage. Crit Care, 2007. 11(4): 220
  15. Keyrouz, S., Diringer, M. Clinical review: Prevention and therapy of vasospasm in subarachnoid haemorrhage. Critical Care, 2007. 11:220
  16. Kaufmann, T.J., et. al. Complications of Diagnostic Cerebral Angiography: Evaluation of 19 826 Consecutive Patients. Radiology. 2007. 243:812-9
  17. Anderson, G.B., et. al. CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2000. 21(6):1011-5.
  18. Daten von Intensivpatienten der Pauls Stradiņš Universitätsklinik mit der primären Diagnose SAB. Wir verglichen die Aufnahme Serum-Glukosespiegel und die Glukosespiegel-
  19. Pluta, R.M. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005. 105:23-56
  20. Dumont, T., Rughani, A., Silver, J., Tranmer, B. Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care. 2009. 11:183-189
  21. Die Studie zeigt, dass Aufnahme-und Initiale 24 Stunden Glukosespiegel prognostische Indikatoren für die potenzielle Entwicklung von ZVS nach SAB sein könnten.
  22. VII. Directory of Academic Teachers My academic teachers in Rīga and Marburg were:
  23. Daankbar, J.W., et. al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010. 14(1):R23
  24. Hino, A. et. al. Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke. 1992. 23:423-426
  25. Lennihan, L. et. al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial. Stroke. 2000. 31(2):383-91
  26. Zwienenberg-Lee, M. et. al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008 39(6):1759
  27. Shiokawa Y, gado-Zygmunt TJ, Arbab MA, Svendgaard NA. Effect of unilateral pre- and postganglionic lesioning of the trigeminal nerve on the development of cerebral vasospasm in the squirrel monkey: angiographic findings. Br J Neurosurg. 1992. 6:445-455
  28. Leslie, J.B., Watkins, W.D. Eicosanoids in the Central Nervous System. J Neurosurg. 1985. 63:659-668.
  29. Chow, M., Dumont, A.S., Kassell, N.F. Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery. 2002. 51:1333-1341
  30. Kerz, T. et. al. Endovascular therapy for vasospasm after aneurysmatic subarachnoid haemorrhage. Br. J. Neurosurg. 2016. 30(5):549-53
  31. Aburto-Murrieta, Y. et. al. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Vasc Endovascular Surg. 2012. 46(6):460
  32. Weir, B., Macdonald, R.L., Stoodley, M. Etiology of cerebral vasospasm. Acta Neurochir Suppl. 1999. 72:27-46
  33. Asano, T. et. al. Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res. 1984. 6:49-53
  34. Cook, D.A., Vollrath, B. Free radicals and intracellular events associated with cerebrovascular spasm. Cardiovasc Res. 1995. 30:493-500
  35. Halliwell B, Gutteridge, M.C. Free radicals in biology and medicine. New York: Oxford University Press. 1999. p 27
  36. Oddo, M., et. al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008. 36(12):3233-8
  37. Polidori, M.C., et. al. Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage. Free Radic Biol Med. 1997. 23:762-767
  38. Widenka, D.C., et. al. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg. 1999. 90:1098-1104
  39. Alberti, O., Becker, R., Benes, L., et al. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg. 2000. 102:78 -83
  40. Van den Gerghe, G. et. al. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001. 345:1359-1367
  41. Vespa, P. et. al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med, 2006. 34(3):850-6
  42. International Union of Pure and Applied Chemistry -The Compendium of Chemical Terminology. 596p
  43. Weir, C.J., Murray, G.D., Dyker, A.G., et al. Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997. 314: 1303-1306
  44. Pluta, R.M., Zauner, A., Morgan, J.K., Muraszko, K.M., Oldfield, E.H. Is vasospasm related to proliferative arteriopathy? J Neurosurg. 1992. 77:740-748
  45. Pluta, R.M., et.al. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg. 1996. 84:648-654
  46. Biller, J., Godersky, J.C., Adams, H.P. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988. 19:1300 -1305
  47. Naidech, A.M., et.al. Moderate Hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care, 2010. 12(2):181-7
  48. Tani, E. Molecular mechanisms involved in development of cerebral vasospasm. Neurosurg Focus. 2002. 12(3):ECP1
  49. Mortalität wurde durch die Glukosespiegel nicht beeinflusst und die Glukose-Mittelwerte der ersten 24 Stunden korrelierten negativ mit der Dauer des Aufenthalts auf der Intensivstation (rs = -0.408, p<0,05).
  50. Charpentier, C. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke, 1999. 30:1402-1408
  51. Miyauchi, T., Masaki, T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol. 1999. 61:391-415
  52. Borel ,C.O., et. al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003. 34:427-433
  53. Kosnik, E.J., Hunt, W.E. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 1976. 45:148-54
  54. Egge, A. et. al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001. 49(3):593-605
  55. Fisher, C.M., Kistler, J.P., Davis, J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980. 6:1-9
  56. Badjatia, N., et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med. 2005. 33(7):1603-9
  57. Sloan, M.A., et. al. Assessment: Transcranial Doppler ultrasonography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004. 62(9):1468-81
  58. Pluta, R.M., Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997. 87:746-751
  59. Inagawa, T., Yahara, K., Ohbayashi, N. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo), 2014. 17;54(6):465-73
  60. Inagawa, T. Risk Factors for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage: A Review of the Literature. World Neurosurg. 2016. 85:56-76
  61. Zhou, C., Yamaguchi, M., Colohan, A.R., Zhang, J.H. Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2005. 25:572-582
  62. Marin, J., Rodriguez-Martinez, M.A. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther. 1997. 75:111-134
  63. Nishizawa, S., Laher, I. Signaling mechanisms in cerebral vasospasm. Trends Cardiovasc Med. 2005. 15:24-34
  64. McGirt, M.J., et. al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke. 2002. 33:2950-2956
  65. Schmutzhard, E., Rabinstein, A.A. Spontaneous subarachnoid hemorrhage and glucose management. Neurocrit Care. 2011. 15(2):281-6
  66. McCowen, K.C., Malhotra, A., Bistrian, B.R. Stress-induced hyperglycaemia. Crit Care Clin. 2001. 17:107-124
  67. Stornelli, S.A., French, J.D. Subarachnoid hemorrhage-factors in prognosis and management. J Neurosurg. 1964. 21:769-780
  68. Kistler, J.P. et. al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology. 1983. 33(4):424- 36
  69. Kistler, J.P., Crowell, R.M., Davis, K.R., et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology. 1983. 33:424 -436
  70. Weir, B., Grace, M., Hansen, J., Rothberg, C. Time course of vasospasm in man. J Neurosurg. 1978 48:173-178
  71. Ravid, J.M. Transient insulin hypoglycemic hemiplegias. Am J Med Sci.1928. 175:756- 69
  72. Kassell, et. al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982. 11(3):337-43
  73. Wintermark, M. et.al. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol. 2006. 27(1):26-34
  74. Mathiesen, T. Vasospasm and delayed ischaemic deficit. Manual of neurosurgery. 1996 Edinburgh: Churchill Livingstone. 428-432p
  75. Cahill, J., Calvert, J.W., Solaroglu, I., Zhang, J.H. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke. 2006. 37:1868- 1874

* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten
© UB Marburg 1997 - 2024 Universitätsbibliothek Marburg